High pressure post-dilatation is necessary to optimize deployment of drug-eluting stents for the treatment of in-stent restenosis

High pressure post-dilatation is necessary to optimize deployment of drug-eluting stents for the treatment of in-stent restenosis

Bibliografske podrobnosti
Main Authors:	Blackman, D, Porto, I, Channon, K, Banning, A
Format:	Conference item
Izdano:	2003

Podobne knjige/članki

Usefulness of high-pressure post-dilatation to optimize deployment of drug-eluting stents for the treatment of diffuse in-stent coronary restenosis.
od: Blackman, D, et al.
Izdano: (2004)

Use of a sirolimus-eluting stent to treat failure of a nonpolymer release paclitaxel-eluting stent implanted for in-stent restenosis.
od: Porto, I, et al.
Izdano: (2005)

Mid-Term Follow-Up of Drug-Eluting Stenting for In-Stent Restenosis: Bare-Metal Stents versus Drug- Eluting Stents
od: Negar Faramarzi, et al.
Izdano: (2015-10-01)

Overview of intracoronary brachytherapy for in-stent restenosis of a drug-eluting stent
od: Sohila Refahi, et al.
Izdano: (2019-03-01)

Risk assessment score for drug eluting stent restenosis
od: Z. A. Gabbasov, et al.
Izdano: (2018-09-01)

Paclitaxel eluting stents versus bare metal stents restenosis
od: Ronald Aroche Aportela, et al.
Izdano: (2021-12-01)

Drug-eluting stents or balloon angioplasty for drug-eluting stent-associated restenosis: An observational follow-up study of first-time versus repeated restenosis
od: Mohamed Aboel-Kassem F. Abdelmegid, et al.
Izdano: (2017-04-01)

Incidence, predictors and management of left main coronary artery stent restenosis: a comprehensive review in the era of drug-eluting stents.
od: De Caterina, A, et al.
Izdano: (2013)

Comparison of Bare metal Vs Drug eluting stents for in-stent Restenosis among Diabetics
od: Kakhaber Etsadashvili, et al.
Izdano: (2011-06-01)

Genetic risk model for in-stent restenosis of second-and third-generation drug-eluting stents
od: Yen-Wen Liu, et al.
Izdano: (2021-09-01)

Classification and patterns of bifurcation in-stent restenosis (BISR) in the second generation drug eluting stent era
od: Omar A. Meelu, MS, et al.
Izdano: (2017-03-01)

In-stent restenosis of drug-eluting stents: clinical presentation and outcomes in a real-world scenario
od: Ganesh Paramasivam, et al.
Izdano: (2019-11-01)

Prognostic Role of Fasting Remnant Cholesterol with In-Stent Restenosis After Drug-Eluting Stent Implantation
od: Luo Y, et al.
Izdano: (2022-02-01)

The sirolimus-eluting Cypher Select coronary stent for the treatment of bare-metal and drug-eluting stent restenosis: insights from the e-SELECT (Multicenter Post-Market Surveillance) registry.
od: Abizaid, A, et al.
Izdano: (2012)

Risk Factors and Incidence for In-Stent Restenosis with Drug-Eluting Stent: A Systematic Review and Meta-Analysis
od: Birong Liu, et al.
Izdano: (2024-12-01)

The Endovascular Therapy for In-Stent Restenosis After Fluoropolymer-Based Drug-Eluting Stent Implantation in Femoropopliteal Lesions
od: Kazunori Horie, MD, et al.
Izdano: (2025-01-01)

The Predictors of Target Lesion Revascularization and Rate of In-Stent Restenosis in the Second-Generation Drug-Eluting Stent Era
od: Chengbin Zheng, et al.
Izdano: (2019-01-01)

Coronary In-Stent Restenosis Predictors following Drug-Eluting Stent Implantation: A Meta-Analysis Study
od: Mohammad Saifur Rohman, et al.
Izdano: (2023-07-01)

In-stent restenosis of drug-eluting stents in patients with diabetes mellitus: Clinical presentation, angiographic features, and outcomes
od: Ganesh Paramasivam, et al.
Izdano: (2019-12-01)

The Role Of Inflammation In Stent Restenosis More Than 1 Year Afetr Drug Eluting Stent Implantation
od: Hasan Shemirani, et al.
Izdano: (2011-09-01)

Safety of MRI early after implantation of a drug-eluting stent.
od: Porto, I, et al.
Izdano: (2004)

Clinical Outcomes of Drug-Eluting versus Bare-Metal In-Stent Restenosis after the Treatment of Drug-Eluting Stent or Drug-Eluting Balloon: A Systematic Review and Meta-Analysis
od: Yi-Xing Yang, et al.
Izdano: (2020-01-01)

Recurrent in-stent restenosis with total occlusion remedied with drug-eluting balloon angioplasty
od: Mohd Shah, Azarisman Shah, et al.
Izdano: (2011)

Do pre-procedural laboratory parameters predict drug-eluting stent restenosis?
od: Aslı Tanındı, et al.
Izdano: (2015-07-01)

Do pre-procedural laboratory parameters predict drug-eluting stent restenosis?
od: Murat Gençbay
Izdano: (2015-07-01)

Application of genetic risk score for in-stent restenosis of second- and third-generation drug-eluting stents in geriatric patients
od: Yu-Ling Hsu, et al.
Izdano: (2023-07-01)

In Stent Restenosis After Drug-Eluting Stent Implantation in a Patient with Polycythemia Vera: A Case Report
od: I Gusti Ayu Ratna Dewi, et al.
Izdano: (2023-06-01)

The effect of sex differences on neointimal characteristics of in-stent restenosis in drug-eluting stents: An optical coherence tomography study
od: Xiaohang Yuan, et al.
Izdano: (2023-08-01)

Combining short stent implantation and drug-eluting stenting for routine use yields a low restenosis rate
od: Dauer Cheryl, et al.
Izdano: (2005-12-01)

Impact of Paclitaxel-Eluting Balloons Compared to Second-Generation Drug-Eluting Stents for of In-Stent Restenosis in a Primarily Acute Coronary Syndrome Population
od: Guillaume Marquis-Gravel, et al.
Izdano: (2017-09-01)

Focal in-stent restenosis and in-stent thrombosis within the same bare-metal stent 5 years after deployment in a saphenous vein graft.
od: Ponnuthurai, F, et al.
Izdano: (2007)

Drug-coated balloons versus drug-eluting stents in patients with in-stent restenosis: An updated meta-analysis with trial sequential analysis
od: Ahmed Abdelaziz, et al.
Izdano: (2024-11-01)

Drug-Eluting Balloons versus Second-Generation Drug-Eluting Stents for Treating In-Stent Restenosis in Coronary Heart Disease after PCI: A Meta-Analysis
od: Wen-Juan Xiu, et al.
Izdano: (2018-01-01)

Comparison of clinical outcomes after drug-eluting balloon and drug-eluting stent use for in-stent restenosis related acute myocardial infarction: a retrospective study
od: Chih-Yuan Fang, et al.
Izdano: (2018-04-01)

Long-Term Clinical Outcome after Sirolimus-Stent Implantation for in Sirolimus-Eluting Stent Restenosis
od: Alain Guidon, et al.
Izdano: (2008-01-01)

Impact of Obstructive Sleep Apnea on In-Stent Restenosis in Coronary Heart Disease Patients after Elective Drug-Eluting Stenting
od: Wenjie Yang, et al.
Izdano: (2025-01-01)

Risk investigation of in-stent restenosis after initial implantation of intracoronary drug-eluting stent in patients with coronary heart disease
od: Hongfei Xi, et al.
Izdano: (2023-03-01)

Outcome of Coronary Edge In-stent Restenosis Management by Restenting Versus Drug-Eluting Balloon
od: Yasser Gaber Metwally, et al.
Izdano: (2024-12-01)

Late stent thrombosis 28 months post implantation of a left main coronary drug-eluting stent.
od: Schrale, R, et al.
Izdano: (2007)

Intravascular ultrasound imaging in the diagnosis and treatment of spontaneous coronary dissection with drug-eluting stents.
od: Porto, I, et al.
Izdano: (2004)